Use of formative research in developing a knowledge translation approach to rotavirus vaccine introduction in developing countries by Simpson, Evan et al.
BioMed  Central
Page 1 of 11
(page number not for citation purposes)
BMC Public Health
Open Access Research article
Use of formative research in developing a knowledge translation 
approach to rotavirus vaccine introduction in developing countries
Evan Simpson*1, Scott Wittet1, Josefina Bonilla2, Kateryna Gamazina3, 
Laura Cooley1 and Jennifer L Winkler1
Address: 1PATH, 1455 NW Leary Way, Seattle, WA 98107 US, 2Federación Red NicaSalud, Managua, Nicaragua and 3PATH-Ukraine, 2A Bankova 
Street, 01601, Kyiv, Ukraine
Email: Evan Simpson* - esimpson@path.org; Scott Wittet - swittet@path.org; Josefina Bonilla - jbonillaben@nicasalud.org.ni; 
Kateryna Gamazina - kgamazina@path.org; Laura Cooley - imadandlaura@earthlink.net; Jennifer L Winkler-j w i n k l e @ p a t h . o r g
* Corresponding author    
Abstract
Background: Rotavirus gastroenteritis is the leading cause of diarrheal disease mortality among children
under five, resulting in 450,000 to 700,000 deaths each year, and another 2 million hospitalizations, mostly
in the developing world. Nearly every child in the world is infected with rotavirus at least once before they
are five years old.
Vaccines to prevent rotavirus or minimize its severity are now becoming available, and have already been
introduced into the public vaccine programs of several Latin American countries. The World Health
Organization (WHO) has made rotavirus vaccine introduction in developing countries a high priority.
The WHOs Guidelines for Vaccine Introduction indicates that a key determinant to achieving vaccine
introduction is the public health priority of the disease, suggesting that where the disease is not a priority
uptake of the vaccine is unlikely. WHO recommends conducting a qualitative analysis of opinions held by
the public health community to determine the perceptions of the disease and the priority given to the
vaccine.
Methods: This paper presents the formative research results of a qualitative survey of public health
providers in five low- and middle-income countries to determine if and to what degree rotavirus is
perceived to be a problem and the priority of a vaccine. Open-ended surveys were carried out through
focus group discussions and one-on-one interviews.
Results: Researchers discovered that in all five countries knowledge of rotavirus was extremely low, and
as a result was not considered a high priority. However, diarrhea among young children was considered
a high priority among public health providers in the three poorest countries with relatively high levels of
child mortality: India, Indonesia, and Nicaragua.
Conclusion: In the poorest countries, advocacy and communication efforts to raise awareness about
rotavirus sufficient for prioritization and accelerated vaccine introduction might benefit from a knowledge
translation approach that delivers information and evidence about rotavirus through the broader context
of diarrheal disease control, an existing priority, and including information about other new interventions,
specifically low-osmolarity oral rehydration solution and zinc treatment.
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Background
Despite impressive public health gains made in the 1980s
and 1990s, severe dehydration caused by diarrheal disease
still contributes significantly to childhood morbidity and
mortality in the developing world. Today, diarrheal dis-
ease is responsible for an estimated 1.6 to 2.4 million
deaths annually [1], making it the second leading infec-
tious disease killer of children under five. Among
diarrheal diseases, rotavirus gastroenteritis is a leading
cause of morbidity and mortality in this population.
Each year, rotavirus is responsible for an estimated
450,000–700,000 deaths among children under five, and
another 2 million are hospitalized [2]. Over 80 percent of
rotavirus deaths occur in developing countries, where
access to emergency treatment such as intravenous rehy-
dration is limited. The primary mode of rotavirus trans-
mission is fecal-oral, and it causes rapid dehydration due
to vomiting and diarrhea.
A unique feature of rotavirus is its global scope. Nearly
every child in the world, regardless of geography, socio-
economic status, or gender will get at least one rotavirus
infection before age five [3].
Among diarrheal diseases, rotavirus is an exception to the
management rules. Traditional diarrheal disease preven-
tion efforts, such as improving hygiene, sanitation, and
access to clean water, are not sufficiently effective in pre-
venting rotavirus, as evidenced by the near universal rate
of infection. And, because of the profuse and persistent
vomiting that usually accompanies severe cases, oral rehy-
dration therapy is a very difficult treatment to successfully
administer. A vaccine is considered to be the most effec-
tive prevention method.
The World Health Organization (WHO) has made the
development and distribution of rotavirus vaccines in
developing countries a high priority [4]. As a result, man-
ufacturers, governments, and global health organizations
are working together with the GAVI Alliance to accelerate
the availability of safe and efficacious rotavirus vaccines
for children in developing countries [5].
In 2006, a three-dose oral rotavirus vaccine developed by
Merck & Co. Inc. was approved for use by the U.S. Food
and Drug Administration (FDA). In addition, a two-dose
oral vaccine developed by GlaxoSmithKline was approved
by the European equivalent of the FDA, the European
Agency for the Evaluation of Medicinal Products. Both
vaccines have demonstrated high levels of safety and effi-
cacy in major clinical trials in the U.S., Latin America, and
Europe [6,7], and as a result the WHO's Strategic Advisory
Group of Experts (SAGE), has indicated that adoption of
rotavirus vaccines in these regions is warranted [8]. In
June, 2007, the GAVI Alliance announced it would subsi-
dize the cost of rotavirus vaccines to GAVI eligible coun-
tries (those with a gross national income of less than
US$1,000 per capita) in Latin America and Europe, mak-
ing these vaccines available to these countries at US$0.30
per course [9].
As of June, 2007, four non-GAVI eligible countries in
Latin America (Brazil, Panama, Venezuela, and El Salva-
dor) have introduced rotavirus vaccine into their
Expanded Program on Immunization (EPI) programs.
Mexico is offering the vaccine free of charge in 10 of its
poorest states, and Nicaragua, a GAVI-eligible country,
has introduced the rotavirus vaccine into the EPI system as
part of a demonstration project with Merck & Co. Numer-
ous other countries around the world have licensed rota-
virus vaccines, allowing them to be sold through the
private sector.
To determine efficacy of these vaccines in developing-
country settings, clinical trials of both vaccines are
planned or are underway in Africa and Asia. If proven effi-
cacious, introducing these vaccines into the public sector
EPI programs of low-income countries is a global health
priority [4]. The question remains however, is this global
prioritization of rotavirus vaccines shared by developing
countries where the disease is relatively unknown?
The WHO has issued general guidelines for vaccine intro-
duction which provide countries with a framework for
considering the evidence about specific diseases and the
operational, technical and policy steps necessary for vac-
cine introduction [10].
The guidelines indicate that the vaccine introduction
process begins by determining the public health priority
of a particular disease, suggesting that in countries where
the disease is not a priority adoption of the vaccine is not
assured. The guidelines recommend conducting qualita-
tive investigations of the public health community and
decision makers to gauge the concern about the disease
and the priority of the vaccine.
This paper summarizes the results of a formative research
survey of public health providers in five low-and middle-
income countries to determine levels of knowledge about
rotavirus and rotavirus vaccines, perceptions of diarrheal
disease as a problem and priority for the public health sys-
tem, and knowledge of the causes, prevention methods,
and treatment of diarrheal disease. The formative research
results presented here utilized focus group discussions
(FGD) and one-on-one, semi-structured interviews to
answer surveys, and were supported by funding provided
by the GAVI Alliance in support of the Rotavirus Vaccine
Program (RVP). RVP is a partnership between WHO, theBMC Public Health 2007, 7:281 http://www.biomedcentral.com/1471-2458/7/281
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U.S. Centers for Disease Control, and PATH, a US-based
international health organization. The mission of RVP is
to accelerate the availability of rotavirus vaccines in devel-
oping countries
The results of the surveys have informed the development
of a knowledge translation approach to bridging the gap
between a global scientific agenda of vaccine develop-
ment, and the local public health agenda of diarrheal dis-
ease control. We hypothesize that this approach–the
Enhanced Diarrheal Disease Control Initiative–may help
prioritize diarrheal disease sufficient for consideration of
the vaccine evidence and potentially prioritization of the
vaccine, as well as consideration of other diarrheal disease
interventions, such as zinc treatment, and oral rehydra-
tion therapy.
Methods
These surveys represent formative research. Formative
research typically utilizes qualitative methods to extract
"information on target audiences beliefs, values, attitudes,
knowledge and behaviors related to the health problem of
interest, and seeks to answer questions about the context
that influences, and is influenced by, these individual fac-
tors"[11]. The surveys were conducted in 2006 using focus
group discussions and one-on-one interviews in five
countries: India, Indonesia, Nicaragua, Thailand, and
Ukraine. Participants were assured that their responses
would not be attributed to them by name and identities
were not recorded. Research methods consisted primarily
of open-ended questionnaires designed to develop a gen-
eral public health perspective of rotavirus and diarrheal
disease by pursuing the following formative research
objectives:
1. Assess current knowledge and attitudes related to
diarrheal disease and its causes, prevention, and treat-
ment, with specific attention paid to rotavirus disease.
2. Explore potential messages and solutions to rotavirus
communication challenges.
Research Subjects
A total of 546 research subjects participated in the study.
Table 1 details the number of subjects by country for the
focus groups and the one-on-one interviews. Subjects
included:
• Physicians (private and public)
• Regional, district, and community level health workers
and their managers
• Pharmacists and drug sellers.
• Nurses, mid-wives, and public health volunteers
• National child health experts, advisors to and officials of
the Ministry of Health
• Staff of international organizations involved in child
health, such as UNICEF and WHO.
(Table 1)
Discussion guide
A brief discussion guide was developed to facilitate the
FGD and one-on-one interviews (Table 2).
Results
Survey findings revealed information about knowledge,
attitudes and practices relating to rotavirus and diarrheal
disease. Table 3 provides illustrative and representative
comments with explanations below.
(Table 3)
A. Perceptions and knowledge of diarrheal disease
In all of the countries surveyed it was widely understood
that serious diarrheal disease morbidity and mortality is a
direct result of dehydration. Differences between the
countries emerged in the level of concern about diarrhea
and the priority of diarrheal disease as a public health
problem.
In India, Indonesia, and Nicaragua, countries with rela-
tively high under-five mortality and high diarrhea-related
mortality (Table 4), nearly all participants in interviews
and FGD indicated that diarrheal disease was a serious
and significant problem in their country, but that as a pri-
ority, diarrhea disease control has slipped.
In these three countries the problem of diarrheal disease
was often described as a reflection of larger cultural or
socio-economic conditions. Poor hygiene and environ-
mental conditions were seen as the major contributing
factors to diarrheal disease, often exacerbated by under-
educated or illiterate young mothers. Further understand-
ing of the disease was greatly hindered in all of the coun-
tries by a lack of diagnostic capacity to identify the causal
pathogens, and a lack of disease surveillance to determine
the disease burden.
Despite this concern and the high level of importance
placed on diarrheal disease, many expressed a perception
that diarrheal disease was no longer receiving the atten-
tion it once had, and that previous diarrheal disease con-
trol education programs had languished or the focus had
shifted to other health issues. In Nicaragua, India, andBMC Public Health 2007, 7:281 http://www.biomedcentral.com/1471-2458/7/281
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Indonesia there was a strong interest in renewed emphasis
on preventing diarrheal disease through health education.
In Thailand, a middle-income country with lower levels of
under-five mortality, diarrheal disease was seen as a rela-
tively insignificant problem due to the wide availability of
treatment and a high degree of community awareness of
prevention and management methods. This view seems to
contradict the data suggesting a relatively high percentage
of under-five deaths caused by diarrhea (Table 4). Hospi-
tal based physicians in Thailand considered severe cases to
be problematic but infrequent. And most community-
level health care workers perceived diarrhea as common
and manageable, with most respondents at all levels indi-
cating that severe dehydration and death from diarrhea
were rare.
In Ukraine, opinions varied significantly as to the serious-
ness of diarrheal disease as a problem in that country,
leading the research team to conclude that there was no
consensus about the priority of diarrheal disease in
Ukraine. Many of the Ukrainian respondents believed that
diarrheal disease was not a major problem, and in
instances of outbreaks, was thought to be well managed in
in-patient and out-patient settings. However, certain med-
ical and child survival specialists, and public health pro-
fessionals at the national and regional levels (oblasts),
voiced a contrary viewpoint, that diarrhea and dehydra-
tion were a serious problem for young children in
Ukraine, despite low mortality from diarrhea.
In India, Indonesia, and Nicaragua, while rehydration
therapies exist, several respondents indicated that many
parents and caregivers wait too long to seek care, or are
unable, or unwilling to do so and was an indicator of
inadequate education about the disease and its potential
severity. Some expressed a view that the delay often stems
from parental beliefs that diarrhea is a common aspect of
early child development, and was a sign of development
and growth, which can lead to delays in care-seeking until
severe symptoms occur.
B. Knowledge of rotavirus and rotavirus vaccines
In all of the countries, except for Nicaragua, awareness
about rotavirus was extremely low. In fact, outside of uni-
versity- or hospital-based pediatric and virology settings,
rotavirus was an illness few in the broader public health
community had heard of or knew anything about.
Table 1: Number of respondents in interviews and focus group discussions by country
Country No. of FGD participants (number of FGDs) No. of individual interviews Total respondents
India (Andhra Pradesh) 75 (17) 25 100
Indonesia 57 (6) 25 82
Nicaragua 136 (15) 50 186
Thailand 44 (8) 41 85
Ukraine 62 (9) 31 93
TOTAL 374 (55) 172 546
Table 2: Discussion Guide
Topic I Diarrheal disease–knowledge and attitudes
Questions a. How serious a public health problem is diarrheal disease here?
b. Relative to other health problems?
c. What are some of the causes of diarrhea?
d. What are some ways that diarrheal disease can be prevented?
e. What are some of the challenges you face in helping parents prevent diarrheal disease?
f. What are challenges related to treating diarrheal disease?
Topic II Rotavirus and rotavirus vaccine–knowledge and attitudes
Questions a. Is rotavirus-related disease a problem here?
b. How serious a problem is it?
c. What kinds of health problems do you see which can be attributed to rotavirus?
d. How can rotavirus disease be prevented?




























































































































Table 3: Representative quotes from focus-groups and interviews
Quote Respondent Country
A. Perceptions and knowledge of diarrheal disease
"The problem of diarrhea is quite serious; it has to do with hygiene habits especially, and with dietary habits." MOH Official Nicaragua
"It is not an important health problem because of low-mortality rate. Parents would seek early medical consultation. Most cases are mild 
diarrhea."
Community Health Nurse Thailand
"Lack of knowledge regarding sanitation and hygiene, and myths and beliefs among rural populations about diarrhea leads to seriousness of 
the cases."
Public Health Care Provider India
"It is a social problem and depends on water supply, and personal nutrition and hygiene." Medical School Professor Ukraine
"Due to negligence, people do not react immediately to the symptoms of the disease." District-level private health care provider India
B. Knowledge of rotavirus and rotavirus vaccines
"We don't know what the rotavirus is." Nurse Ukraine
". . .Maybe a little [knowledge of rotavirus] . . . I only know that it causes diarrhea." General practitioner Thailand
"Rotavirus is prevailing in western countries only. Diagnosis for rotavirus is not done in India. Not aware of vaccine." State level health advisor India
"It is a water borne disease. But one does not know about its prevalence in India." Public health provider India
"Not yet, not yet. I have not been informed about rotavirus diarrhea or the vaccine." Policy maker Indonesia
C. Other causes of diarrheal disease
"We know that viruses are the main cause of diarrhea, but don't know which." Pediatrician Ukraine
"The causes of diarrhea are mostly food-borne infections, both bacterial and viruses. Most of our cases are viral." General practitioner Thailand
"Eating mutton and chicken, eating food without washing hands, and living in unclean surroundings are causes of diarrhea." Private Health Care Provider India
D. Prevention of Diarrheal Disease
"Invest in campaign programs, especially during the peak season of diarrhea. Collaborate with community health centers focusing on hand 
washing, clean and safe food."
Advisor, Ministry of Health Thailand
"Dispose dust and garbage on day to day basis. Dispose of infant stools properly and wash hands." Village-level Public Health Provider India
"In order to prevent diarrhea: exclusive breastfeeding." Ministry of Health official Nicaragua
"In previous times we had a lot of printing materials and posters regarding prevention of diarrheal disease and personal hygiene, now we 
don't have these."
Pharmacist Ukraine
E. Diarrheal Disease Treatment
"Oral rehydration therapy is the best." Ministry of Health Official Nicaragua
"Most physicians don't even realize that decrease in death rates among infants in the past few years is due to broader implementation of 
rehydration therapy."
Medical School Professor Ukraine
"The challenges [for treatment]: the culture of each individual, self medication, many purge their children and they come in dehydrated, they 
stop giving them food because they say it hurts them."
Private physician Nicaragua
"Mothers stop breast feeding the child with diarrhea. This leads to seriousness." Public Health care provider, Village level, Indian Village Level Public Health Care Provider India
"People frequently use self-treatment with antibiotics, and this is bad." Pediatrician Ukraine
F. Zinc treatment
"Do not know much [about zinc]. It is still under study." District-Level Public Health Care Provider India
"We have never heard about zinc but think that regular use of yogurts can protect from gastroenteritis." Pediatrician UkraineBMC Public Health 2007, 7:281 http://www.biomedcentral.com/1471-2458/7/281
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Those few with any familiarity with rotavirus did not dif-
ferentiate it from other causes of diarrheal disease in terms
of its transmission, prevention and treatment. They often
expressed inaccurate information about the disease, and
indicated, incorrectly, that improved hygiene and access
to clean water would adequately prevent rotavirus. Many
also indicated that ORT was a viable treatment option,
however, in the face of severe disease, ORT is very difficult
to administer outside of clinical settings due to the pro-
fuse vomiting that occurs.
In 2004 and 2005, Nicaragua and several other Central
American countries faced an exceptionally severe rotavi-
rus season. Several hundred deaths in the region led to
declarations of public health emergencies, and significant
public warnings and information campaigns to reduce the
number of sick children[12]. This helped sensitize the
country to rotavirus, and certainly contributed to
increased awareness among providers. Despite this high
visibility, a number of participants expressed a lack of
awareness about the disease. Not surprisingly, while few
had heard of the disease, even fewer were aware of a vac-
cine or its potential.
Knowledge of rotavirus was so low in all countries that
facilitators and interviewers were not able to test potential
messages about rotavirus and the vaccine that might be
used in building awareness about the disease. The
respondents could not effectively respond without further
information about the disease and the vaccine.
Regardless of their knowledge of the disease, discussions
about rotavirus vaccines revealed some skepticism about
whether or not the disease burden sufficiently warranted
a vaccine. Even among knowledgeable pediatric special-
ists, lack of information about disease burden prevented
them from making a judgment about the priority of the
disease and the vaccine. In addition, in Indonesia and
India several participants assumed that the vaccine would
be expensive and likely out of reach financially for the
poorest populations.
C. Other causes of diarrheal disease
In almost all instances, discussions about the cause of
diarrheal disease centered around the transmission of
diarrheal disease, such as poor hygiene and water. Almost
no mention was made of specific pathogens, although
among physicians and others with advanced public health
training, there was acknowledgement that there are viral
and bacterial causes.
All of the subjects identified poor sanitation and hygiene
behaviors, such as unsanitary food handling and storage,
lack of hand washing after latrine use, and improper waste
disposal, as the most important and common causes of
diarrhea. In addition, lack of access to potable water was
also cited as a frequent cause of diarrheal disease.
Respondents in all the countries cited the lack of labora-
tory diagnostics and surveillance as a barrier to determin-
ing the type and causal agent of diarrheal disease, often
leading to potentially inappropriate treatment recom-
mendations.
D. Prevention of diarrheal disease
Prevention was closely linked to cause. Public education
was cited as the most important prevention effort, with
particular focus on parents, in order to improve hygiene
practices and convey the importance of clean water. In
addition, respondents cited education about exclusive
breastfeeding of infants as another important preventive
approach.
In Ukraine, educating food handlers in restaurants and
shops was thought to be the most effective and efficient
intervention to prevent diarrheal disease. In Nicaragua,
there was interest in behavior change efforts aimed at par-
ents to improve overall hygiene. In India, and to some
extent Indonesia, there was strong interest within the pub-
lic health community in renewing the focus on diarrheal
disease prevention at the community and national levels.
In all of the countries findings indicated that community
education campaigns were no longer being conducted to
the extent and with the frequency they once were.
E. Treatment
The use of oral rehydration solution was frequently cited
as a successful treatment. In India, several respondents
indicated that despite past public education efforts, use of
oral rehydration therapy was relatively low. In Nicaragua,
some participants indicated that many parents did not use
oral rehydration solution appropriately.
In India, Thailand, and Indonesia, the use of various oral
rehydration therapies such as milks, tea, water, juice and
Table 4: Under-5 mortality rates and percentage of under-5 
mortality due to diarrhea in survey countries
Country Under-5 Mortality 
Rate per 1,000 live 
births (2005)
Percentage of under-5 
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other liquids were often mentioned as important treat-
ment methods.
In several countries ineffective and potentially dangerous
diarrheal disease management practices were said to be
practiced. In Nicaragua, India and Indonesia, in particu-
lar, purging with laxatives and other agents, stopping
breastfeeding, massage, and withholding food and water
were said to be common practices, particularly among
low-literate populations. In all of the countries, inappro-
priate use of antibiotics and anti-diarrheal medications
were also frequently mentioned.
F. Zinc treatment
Recent studies indicate that treating diarrhea with zinc can
significantly reduce the burden of dehydration caused by
diarrheal disease among children under 5 in developing
countries [13]. These studies suggest that 20 mg of zinc
per day over 10–14 days at the onset of diarrhea can sig-
nificantly reduce the duration and severity of the illness,
stool output, and the need for hospitalization. Zinc may
also prevent future episodes of the disease for up to 3
months, and has been shown to reduce the inappropriate
use of antibiotics.
Questions and considerations of zinc treatment were
added late to the discussion guide, as a result, discussions
about zinc were conducted only in the interviews and
FGD held in India, Ukraine, and Thailand. Participants
were asked about their knowledge of zinc as an interven-
tion for controlling diarrhea. Most indicated little or no
knowledge of zinc as a treatment for diarrhea.
Discussion
These formative survey results confirm what has been
reported elsewhere, that rotavirus is a relatively unknown
disease [14], and in developing countries, except among a
narrow group of highly specialized medical professionals,
few in the public health community have heard of or are
knowledgeable of rotavirus. This lack of awareness by the
public health community is a significant barrier to the pri-
oritization of the disease, which WHO states is the first
step towards consideration of the evidence for new vac-
cines [10].
Building awareness of rotavirus in the public health com-
munities of developing countries to a level sufficient for
consideration of the evidence and subsequent prioritiza-
tion of the disease is a challenging task. Passive measures
to present rotavirus-specific evidence through peer-
reviewed articles in the scientific literature and presenta-
tions, usually in academic or scientific settings, are neces-
sary but likely insufficient for prioritization. A search of
rotavirus on the National Library of Medicine's PubMed
database identifies over 7,000 peer-reviewed articles have
been published since rotavirus was discovered in 1973,
and undoubtedly countless presentations made, yet the
disease remains virtually unknown within the public
health community of developing countries where the
impact of the disease is most severe. Clearly a gap exists
between the global evidence base about rotavirus and
local knowledge and awareness.
The challenge of bridging this gap is compounded by a
significant slowdown in the broader diarrheal disease
control effort at the global and national levels. While the
problem of diarrheal disease remains a significant cause
of morbidity and mortality, the surveys indicate a wide-
spread belief that diarrheal disease programming has
diminished in recent years. This perspective is supported
by evidence suggesting that coverage of existing diarrheal
disease control interventions such as oral rehydration
therapy has leveled off, or in some countries, actually
decreased [15]. One reason for this may be that in many
countries the Control Diarrheal Disease programs, which
focused resources and attention on preventing and treat-
ing diarrheal disease so successfully in the 1980's and
1990's, have been subsumed by the Integrated Manage-
ment of Childhood Illness (IMCI) approach. This may
have had the unintended consequence of attenuating
diarrheal disease control in favor of a more generalized
child health effort, where a range of child health messages
and resources are co-mingled.
Secondly, the global attention focused on AIDS, TB and
malaria, as evidenced by the significant global and
national resources being directed to those concerns, has
had the effect of marginalizing other child health issues,
including diarrheal disease, and progress towards
improved child survival in developing countries has
slowed [16].
Renewing commitment to diarrheal disease control
What is needed is a renewed commitment to reducing the
burden of diarrheal disease among children in poor coun-
tries, and the development of rotavirus vaccines and zinc
treatment provide a catalyst for this renewal which in turn
may accelerate their introduction.
We hypothesize that a "knowledge translation" approach
could provide a catalytic framework for rebuilding
momentum for diarrheal disease control and overcoming
the lack of awareness of rotavirus and zinc by demonstrat-
ing the relevance of these new interventions to the
broader public health agenda of diarrheal disease control.
Knowledge translation is a nascent global health para-
digm with several definitions, but can be summarized as
a theoretical process of bridging global scientific evidence
with local public health experience, practice and policiesBMC Public Health 2007, 7:281 http://www.biomedcentral.com/1471-2458/7/281
Page 8 of 11
(page number not for citation purposes)
to move evidence into policy and action [17,18]. This
bridging relies partly on "contextualizing" the evidence,
which a panel of knowledge translation experts convened
by the WHO suggested, "implies that evidence is plural
and that the implementability of good 'global' evidence
must be triangulated with local knowledge" [17].
The results of this survey indicate that, while rotavirus is
little known and as a result not considered a major prior-
ity, diarrheal disease remains a significant concern in poor
countries, as represented by Nicaragua, Indonesia and
India. The results of the survey also indicate a broad
understanding of the causes, prevention, and treatments
of diarrheal disease generally. Dirty water, poor sanitation
and hygiene practices were frequently implicated as the
cause of diarrhea. While these are not necessarily the
causes of diarrhea, they are certainly the transmission
routs of pathogens, and this study indicates that past
efforts to educate the public health community about the
importance of improved water and sanitation have been
successful. Similarly, oral rehydration therapy, home
management, and breastfeeding, were frequently men-
tioned as critical components to controlling diarrhea.
The strong knowledge base of existing diarrheal disease
control strategies provides the appropriate contextual
framework for reaching out with information and evi-
dence about rotavirus and rotavirus vaccines, as well as
other diarrheal disease control interventions, as opposed
to launching independent, vertical approaches to knowl-
edge building and demand creation. By integrating infor-
mation about rotavirus with other diarrheal disease
interventions, it may be possible to create a corresponding
priority-by-association for rotavirus. Moreover, the dis-
cussions revealed that in the poorest countries there is a
desire for renewed attention to diarrheal disease, further
indicating receptiveness for viable solutions to diarrheal
disease.
Support for an integrated approach
The notion of integrating rotavirus into the broader land-
scape of diarrheal disease to build greater association and
awareness is supported by the findings of the Diseases of
the Most Impoverished (DOMI) Program of the Interna-
tional Vaccine Institute. The DOMI Program was estab-
lished to accelerate the development and use of existing
and future enteric vaccines against typhoid fever, cholera,
and shigellosis. Through extensive surveys in developing
countries, DOMI researchers found that county-level deci-
sion makers consider enteric vaccines, of which rotavirus
is one, as only one component of diarrheal disease control
efforts that include everything from public education to
improvements in water, sanitation and hygiene, as well as
vaccines [19].
An integrated approach also provides opportunities to
reinforce existing interventions, such as ORT, which as
mentioned above, suffers from stagnating coverage, but
because of its effectiveness should remain a cornerstone of
any diarrheal disease control effort. This approach may
also help overcome the "replacement effect" in which
some caregivers may assume incorrectly that one interven-
tion, such as a rotavirus vaccine, replaces the need for
other interventions. This phenomenon was of concern
initially to researchers conducting field trials of zinc treat-
ment, who believed that caregivers might replace the use
of ORS with zinc, when in fact both interventions are nec-
essary. To overcome this, they co-promoted zinc and ORS,
and found that this integrated approach resulted in an
increased use of both interventions [20].
Rotavirus vaccine will only prevent rotavirus, it is not
intended to prevent other forms of diarrhea, and as a
result co-promotion or an integrated approach emphasiz-
ing the continued use of other interventions for prevent-
ing and treating other forms of diarrhea is warranted. In
fact, WHO's Strategic Advisory Group of Experts has rec-
ommended the development of strategies to prevent any
misinterpretation that rotavirus vaccine could prevent
other childhood diarrhea [21]. Integrating rotavirus vac-
cines into a broader effort could help minimize the risk of
replacement.
Instituting an integrated approach also finds support in
the Global Immunization Vision and Strategy (GIVS), the
WHO and UNICEF's 10-year strategic plan for expanding
access to existing vaccine and introducing new vaccines.
GIVS identifies as one of its four strategic areas the integra-
tion of immunizations with other health interventions
[22]. Clearly, including rotavirus vaccine in a broader con-
text of diarrheal disease interventions is supportive of this
strategy.
Recommendations
Towards an integrated diarrheal disease control approach
Based on the results of this survey, the authors have pro-
posed a knowledge translation strategy that raises aware-
ness about new and existing diarrheal disease control
measures using an integrated framework. This approach–
the Enhanced Diarrheal Disease Control Initiative
(EDD)–integrates information and evidence about rotavi-
rus and rotavirus vaccines, zinc treatment, and the new
formulation of low-osmolarity ORS, as well as informa-
tion to reinforce the use of existing interventions such as
ORT, exclusive breastfeeding, and improvements in sani-
tation and hygiene (Figure 1). This framework is also
designed to accommodate future interventions such as
vaccines for cholera, typhoid, ETEC, and Shigella, or clean
water technologies.BMC Public Health 2007, 7:281 http://www.biomedcentral.com/1471-2458/7/281
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The goal of EDD is to stimulate decision makers in devel-
oping countries to consider evidence about new and exist-
ing interventions for diarrheal disease control. It relies on
the establishment of a public health coalition represent-
ing a range of disciplines concerned with diarrheal disease
(pediatrics, nutrition, immunization, sanitation, etc.) to
begin the knowledge translation process aimed at the fol-
lowing objectives:
1. Emphasize to decision-makers the importance of
diarrheal disease as a public health priority and the need
for new interventions.
2. Present the evidence about new interventions for
diarrheal disease control to appropriate stakeholders in a
manner reflective of local knowledge, experience, and
practice.
3. Reinforce the importance of existing diarrheal disease
interventions, such as ORT, breast feeding, and improved
sanitation and hygiene
With support from the GAVI Alliance, EDD is being
piloted in several countries in Latin America and Asia.
Early indications suggest that local diarrheal disease coali-
tions have used the concept successfully to raise awareness
for the new interventions throughout the public health
system, stimulate policy changes such as the listing of zinc
as an essential drug, and in one country, may have spurred
the decision to undertake a demonstration project of rota-
virus vaccine. Perhaps most importantly, diarrheal disease
is once again near the top of the public health agenda in
these countries, EDD having catalyzed consideration of
both the problem and the solutions. Formal impact eval-
uations of EDD pilot projects are planned. We believe that
in some countries the EDD strategy will help RVP achieve
its mission of accelerating introduction of rotavirus vac-
cine by raising the awareness of the vaccines in the context
of a renewed diarrheal disease control strategy.
Limitations
This qualitative study was conducted to develop a gener-
alized public health view of rotavirus and diarrheal dis-
ease in developing countries, particularly with regard to
the priority and concern for diarrheal disease and its
causes. As a result, we did not stratify nor quantify the
data, choosing instead to find common themes and per-
spectives.
As with many qualitative studies, the responses are open
to bias from those collecting the information. In addition,
FGD are often limited by the potential of participants to
be unwilling to say certain things in public.
Greater attention should be paid in future studies to quan-
tifying levels of knowledge and attitudes by particular sec-
tors of the public health community in order to further
refine communication, education and information pro-
grams.
Finally, the paper recommends a knowledge translation
strategy, fully accepting the fact that there are few if any
studies indicating that knowledge translation is effective
in accelerating adoption of policies or interventions.
However, the authors believe that as a theory knowledge
translation has merit. The Enhanced Diarrheal Disease
Control Initiative adopts the knowledge translation the-
ory to achieve the desired objectives of rebuilding
momentum for diarrheal disease control, accelerating
introduction of new interventions, and reinforcing use of
established interventions.
Conclusion
RVP was established to accelerate the introduction of rota-
virus vaccines but found that the lack of knowledge of
rotavirus by the public health community in some devel-
oping countries was insufficient to prioritize the vaccine
as needed for uptake. In addition, it was found that the
broader diarrheal disease control effort has lost consider-
able momentum, and is currently a weak platform for
advancing new interventions.
The availability of research evidence that includes rotavi-
rus disease burden estimates and clinical trial results may
be enough for global prioritization, even if the disease are
Enhanced Diarrheal Disease Control Framework Figure 1
Enhanced Diarrheal Disease Control Framework.BMC Public Health 2007, 7:281 http://www.biomedcentral.com/1471-2458/7/281
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relatively obscure or unknown. But in developing coun-
tries where lack of familiarity with rotavirus and pre-exist-
ing priorities compete for scarce resources, global
evidence alone may not be enough to guarantee prioriti-
zation of the disease and uptake of the vaccine.
Knowledge translation offers one potential approach to
link global evidence with a local context of diarrheal dis-
ease control knowledge, experience and practice in order
to build an association between rotavirus and the
expressed priority of diarrheal disease.
The EDD approach is designed to rekindle interest in
diarrheal disease control at the country level, and to put
knowledge translation into practice by stimulating the pri-
oritization and uptake of rotavirus vaccines, as well as zinc
treatment, and to reinforce use of existing diarrheal dis-
ease control measures and prevent child deaths.
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